Clinical Research Directory
Browse clinical research sites, groups, and studies.
CIRculating CANcer MAster-Protocol
Sponsor: Hospices Civils de Lyon
Summary
This exploratory study will focus on the development of the analyses of blood biomarkers to better understand the circulating biomarkers associated with cancer diagnosis, treatment efficacy and progressive disease
Official title: MAster Protocol Studying the Impact of Blood Biopsy on Screening, Diagnosis, Diagnostic and Follow-up of Solid Cancer in Adult
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
6000
Start Date
2022-12-05
Completion Date
2047-12-01
Last Updated
2023-07-24
Healthy Volunteers
No
Conditions
Interventions
Blood sampling for biomarker analysis (microRNA, circulating DNA…)
From one to four blood samplings: at diagnosis, after the first cycle of treatment, end of treatment, progressive disease (or end of study).
Locations (5)
Service de Pneumologie Hôpital Louis Pradel / Groupement Hospitalier Est
Bron, France
Service de Pneumologie Hôpital Croix-Rousse / Groupement Hospitalier Nord
Lyon, France
Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique Hôpital Lyon-Sud / Groupement Hospitalier Sud
Pierre-Bénite, France
Oncologie médicale Hôpital Lyon-Sud / Groupement Hospitalier Sud
Pierre-Bénite, France
Service de dermatologie Hôpital Lyon-Sud / Groupement Hospitalier Sud
Pierre-Bénite, France